Stay updated with breaking news from Mitchell Steiner. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Biotech company Veru announced Tuesday that the results of a COVID-19 treatment trial indicate that one of the firm's anti-cancer treatments was effective in reducing the risk of death among coronavirus patients.
Veru (NASDAQ: VERU), an Oncology Biopharmaceutical Company, skyrocketed to double digits after reporting beneficial data regarding a cancer drug that could also fight Covid-19.
Stock futures dip as Wall Street's rally to records is set to take a breather (SPY -0.2%). The biggest premarket movers: Coty, Take-Two Interactive, Chegg. Here is the current market situation from CNN Money European markets are mixed. The CAC 40 is higher by 0.47%, while the DAX is leading the FTSE 100 lower. They are down 0.42% and 0.03% respectively. What Is Moving the Markets Here are the headlines moving the markets. The Oil Deal That Could Destroy Iraq From Within The new Biden Administration has largely been focused on fulfilling its election promises in its first month in power. Af...
Veru Announces Nature Medicine Publication Demonstrating that Enobosarm, an Androgen Receptor Targeted Agent, Inhibits Hormone Receptor Positive Metastatic Breast Cancer that has Become Resistant to Estrogen Receptor Targeted Endocrine and CDK4/6 Inhibitor Therapies January 19, 2021 08:30 ET | Source: Veru Inc. Veru Inc. Miami, Florida, UNITED STATES --International Study Establishes the Role of Androgen Receptor as a Tumor Suppressor in ER+ Advanced Breast Cancer-- --Preclinical Studies Support Enobosarm’s Novel Mechanism of Action as an AR Acti...
Biotech Veru's Treatment Could Be a Game Changer, but What About the Stock? Let's check out the charts of this biotech name. Stocks quotes in this article: VERU For his second "Executive Decision" segment of Mad Money Monday evening, Jim Cramer spoke with Dr. Mitchell Steiner, chairman, president and CEO of Veru (VERU) , a biotech leading a charge against breast and prostate cancer. Steiner explained that Veru's goal is to change the standard of care for patients diagnosed with breast or prostate cancer. He said those with breast cancer don't want the side...